Background Vitamin D receptor (VDR) gene polymorphisms have been inconsistently associated with bone mineral density (BMD). To precisely evaluate the associations between three VDR gene polymorphisms and BMD, we performed a large-scale representative study of the Japanese female population.
Osteoporotic fracture is one of the leading causes of disability in elderly people in developed countries, including Japan. [1] [2] [3] The prevention of osteoporosis is of great importance, both in maintaining the quality of life of elderly people and in reducing medical expenditures for the treatment of fractures. [4] [5] [6] Low bone mineral density (BMD) is the most prominent risk factor for osteoporotic fractures. Previous twin and family studies have suggested that genetic factors play an important role in regulating BMD. [7] [8] [9] In 1994, Morrison et al. reported a strong relationship between BMD and restriction fragment length polymorphism (RFLP) based on BsmI endonuclease digestion at the vitamin D receptor (VDR) gene locus in Caucasian women. 10 This report revealed the possibility that a single nucleotide polymorphism (SNP) may result in susceptibility to osteoporosis. Since then, a number of other candidate genes have been studied in relation to BMD or the pathogenesis of osteoporosis. [11] [12] [13] [14] However, studies on VDR polymorphisms provide the greatest volume of data to date.
Four common RFLP have been detected: one each at the BsmI, ApaI, and TaqI restriction sites in intron 8 and exon 9, 10 and one at the FokI restriction sites in the translation initiation site of the VDR gene. [15] [16] [17] Many studies have examined the associations between these polymorphisms and BMD at various skeletal sites with conflicting results. [18] [19] [20] [21] There are several possible reasons for these discrepancies. First, the sample sizes of previous studies were too small, and consequently their statistical power was limited. Second, the samples of the previous studies were recruited on a voluntary basis, making self-selection biases inevitable. Third, some previous studies did not allow for confounding due to heterogeneity across the different allele groups in genetic background, age, menstrual status, body size, or due to lifestyle factors including dietary calcium intake, physical activity, and smoking habits. [22] [23] [24] Fourth, linkage disequilibrium may generate a false relationship between the VDR genotype and BMD, and this may exist only in some ethnic groups. 25 Most studies on this topic have been performed on Caucasian people. It is important to clarify the effect of VDR genotypes on the BMD in other ethnic populations as well. There are fewer studies evaluating the association of both start codon polymorphism (FokI) and 3' end polymorphisms (BsmI, ApaI, and TaqI) simultaneously with BMD in Asian people 26 than there are in Caucasian people. [27] [28] [29] [30] To overcome these problems, we have launched a large-scale cohort study on representative samples of the Japanese female population, called the 'Japanese Population-based Osteoporosis (JPOS) Study'. In this report, we present the associations of three previously reported polymorphisms at ApaI, TaqI, and FokI sites of the VDR gene with BMD and its change over time.
Subjects and Methods

Subjects
We randomly selected 4550 women aged 15-79 years according to resident registrations in seven municipalities distributed throughout Japan involved in the JPOS baseline study of 1996. 31 The genetic analyses were performed on samples from three of the seven municipalities, and the follow-up study of 1999 was conducted in the same three areas. The study areas were as follows: Hirara city in Okinawa, a southern island in a subtropical zone, Nishi-Aizu, a town located in mountain area in the middle part of Japan, and Sangawa, a town in Shikoku Island facing Seto inland sea. We selected 50 subjects from each of the 5-year age groups ranging from 15 to 79 years in each of the three study areas, that is, 650 subjects for each area and 1950 in total.
Written informed consent regarding all the study procedures was obtained from each subject in advance.
BMD measurement
We measured the BMD of the subjects by dual energy X-ray absorptiometry (DXA) at the lumbar spine and right hip (QDR4500A, Hologic Inc., USA) in postero-anterior projection and the non-dominant distal forearm (pDXA, Norland/Stratec, USA/FRG) in both baseline and follow-up studies. If the subjects had a history of fractures or bone disease in the right hip or non-dominant forearm, the other side was scanned. Morphometry of the spine was performed with QDR4500A, in order to exclude from the analysis BMD data of subjects with fractures in the lumbar spine.
The densitometric raw data of QDR4500A taken at the appropriate region of interest (ROI) were analysed by one radiologist (YS) and confirmed by one physician (MI). We obtained the BMD (g/cm 2 ) of the second through fourth lumbar vertebrae and of the femoral neck. The analysis of the densitometric data from pDXA was made automatically immediately after scanning and yielded the BMD of the distal 1/3 site of the radius and the ultradistal site of the forearm (the ultradistal ROI spans 10 mm of the lowest BMD region in the distal forearm).
The short-term precision of the in vivo BMD measurement, calculated from five measurements on different days for each of five volunteers, were 1.2%, 1.6%, and 1.2% (coefficient of variation: CV) for the spine, femoral neck, and distal 1/3 site of the radius, respectively. No remarkable drift in the BMD value of a spine or forearm phantom was observed throughout the study, the in vitro CV being 0.40% and 0.34%, respectively. 31 The subjects underwent BMD measurement at baseline and follow-up studies. The change in BMD was expressed as the annualized percentage change from the baseline BMD.
Interviews
Detailed interviews were performed during both the baseline and follow-up studies by trained nurses according to a questionnaire which was delivered to and was completed by the subject beforehand. The questionnaire included questions regarding menstrual history and menopausal status, history and present status of gynaecological and other diseases or medications which may affect bone metabolism, and lifestyle factors such as smoking, drinking, exercise, and dietary habits.
Another interview was conducted by trained dietitians utilizing a validated food frequency questionnaire, 32 in order to estimate the dietary calcium intake for each subject. This questionnaire mentioned 26 items of commonly eaten calciumrich foods in Japan and formed the basis of an estimate of daily calcium intake.
According to the menstrual information obtained from the interviews, the subjects who menstruated regularly at the time of the baseline or follow-up surveys were judged to be premenopausal, while those who had entered menopause у6 months prior to either survey were grouped as postmenopausal women. Subjects with hysterectomy-induced menopause or whose age at menopause could not be determined were classified as postmenopausal women if they were Ͼ57 years at the time of either survey. In all, 95% of the Japanese women aged у57 are postmenopausal. 31 Subjects younger than 57 years whose age at menopause could not be determined were excluded from the analysis stratified by menopausal status.
Body size and grip strength measurements
The height (cm) and weight (kg) of the subjects were measured with an automatic scale (Body Measure 2, Takei Kagaku Co., Tokyo, Japan). The body mass index (BMI in kg/m 2 ) was calculated as weight (kg) divided by height (m) squared. The peak strength of the grip was measured with a strain gauge dynamometer (TKKϪ5101, Takei Kagaku Co., Tokyo, Japan). We took several measurements and settled on the maximum value for each hand; the average of the maximum values for both hands was used as the representative grip strength of each subject.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes collected from the subjects at baseline in three municipalities. The FokI polymorphism in exon 2 of the VDR gene was detected by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method previously described by Gross et al., 15 with the primers shown in Table 1 .
The polymorphisms determined by the ApaI and TaqI restriction sites within intron 8 and exon 9 of the VDR gene were assessed by a novel allelic discrimination TaqMan assay 33 (Applied Biosystems Japan Ltd., Tokyo, Japan) with two allele specific fluorogenic probes using ABI PRISM 7700 Sequence Detection System (Applied Biosystems Japan Ltd., Tokyo, Japan). DNA sequences obtained for a 740-base pair fragment of the VDR gene, including the ApaI and TaqI restriction sites, revealed 99% and 98% homology, respectively, to the sequence referred by the accession number AC004466. With the help of Primer Express program (Applied Biosystems Japan, Ltd., Tokyo, Japan), we designed the optimum sequence of the primers or probes for efficient PCR, based on our sequencing analysis. The loci of the amplified PCR fragments including the ApaI and TaqI polymorphism sites are shown in Figure 1B . The assay includes proprietary non-labelled forward and reverse primers along with two proprietary fluorescent TaqMan oligonucleotide probes as follows: allele 1-specific probe (denoted as probe 1 in Table 1 ) labelled with VIC or TET (tetrachlorocarboxyfluorescein) fluorophore, and allele 2-specific probe (denoted as probe 2 in Table 1 ) labelled with FAM (carboxyfluorescein) fluorophore. The VIC, TET, or FAM reporter dye is covalently attached to the 5' terminal base of the two probes and the fluorescent with TAMRA (carboxytetramethylrhodamine) quencher dye is attached to the 3' ends. The probes are capable of differentially hybridizing to the amplicons generated during PCR and selectively reporting their respective alleles. Each 25 µl PCR mixture contained 100-300 ng of DNA of the subjects, 12.5 µl of TaqMan Universal PCR Master Mix, (Applied Biosystems Japan, Ltd., Tokyo, Japan), 100-200 nM of primers, and 100 nM of each both probe. Real-time PCR was performed with an ABI Prism 7700 Sequence Detection System under the following conditions: 50ЊC for 2 minutes, 95ЊC for 10 minutes, and then 40 cycles of amplification (denaturation at 92ЊC for 15 seconds, annealing/extension at 63ЊC for 60 seconds). Each allele genotyping was confirmed using every six allele 1 standard and allele 2 standard homozygous template and control without template, and using Sequence Detection System (SDS) software (Applied Biosystems Japan, Ltd., Tokyo, Japan).
The haplotype of TaqI and ApaI polymorphisms was examined using the PCR-RFLP method. Briefly, a 217-bp fragment from the VDR gene flanking the ApaI and TaqI polymorphism sites was amplified by PCR using a forward primer (nt121-144) in intron 8 and a reverse primer (nt337-316) in exon 9 (shown in Table 1 and Figure 1B ) under standard conditions. The PCR products were digested for 2 hours with ApaI at 37ЊC and subsequently for 1 hour with TaqI at 65ЊC. The genotypes were determined by ethidium bromide and UVB illumination of the fragments separated on VDR GENOTYPE IN REPRESENTATIVE SAMPLES 981 The single nucleotide polymorphisms are shown in bold.
The reporter dye attached to the 5' terminal base of TaqMan probe are shown in bold. gels of 3.5% NuSieve GTG agarose (FMC Corp. BioProducts, Rockland, ME, USA). Absence and presence of the ApaI and TaqI sites are denoted A and a, and T and t, respectively. The sequences of the primers and probes used in this study are given in Table 1 . The loci of the polymorphic sites and allele coding are shown in Figure 1A .
Statistics
Data are presented as mean ± standard error of mean (SEM). Differences in basic characteristics, baseline BMD, and change in BMD across the different genotype or haplotype groups were tested using non-paired student's t-test and analysis of variance (ANOVA), with Bonferroni's correction for multiple comparisons. Where necessary, further comparisons of BMD adjusted for confounding factor such as body size 24, 34 were performed by analysis of covariance (ANCOVA). All statistical analyses were performed using the SPSS system for personal computers (Release 10.0.7, SPSS Japan Inc., Tokyo, Japan).
Results
Basic characteristics of the subjects
Among the 1950 subjects selected, 1652 women (84.7%) completed the study. Those subjects with a history or apparent present involvement of any disease affecting bone metabolism, such as amenorrhoea, oligomenorrhoea, bilateral oophorectomy, diseases of the parathyroid gland, rheumatoid arthritis, or diabetes mellitus as found during interviews or laboratory tests (including serum calcium, inorganic phosphorus and parathyroid hormone levels) were excluded from the analyses. Also excluded were subjects who were being administered drugs affecting bone turnover, such as calcium, oestrogens, vitamin D, calcitonin, or glucocorticoids. Subjects whose DNA could not be extracted were also excluded. Consequently, 218 women were excluded from further analysis and the remaining 1434 women served as the representative samples of Japanese women. Data on BMD at the spine of the subjects with vertebral fractures 35 or fourth grade osteophytes in Nathan's classification, 36 or on BMD at the hip or forearm showing deformity in the ROI were excluded from the analysis. Table 2 shows the basic characteristics of the subjects grouped according to menopausal status at baseline. The postmenopausal women were older, shorter in height, lighter in weight, lower in grip strength, and greater in BMI than the premenopausal women. The age at menarche and dietary calcium intake were lower in the premenopausal women than in the postmenopausal women. Baseline BMD values at the lumbar spine, femoral neck, distal 1/3 site of the radius, and the ultradistal site were higher in the premenopausal women than in the postmenopausal women. Values are means ± SEM.
Each characteristic was different between premenopausal and postmenopausal women significantly (P Ͻ 0.01).
VDR genotype distribution
The frequencies of genotypes and alleles of the ApaI, TaqI, and FokI polymorphisms in the subjects are shown in Table 3 . No significant deviation from the Hardy-Weinberg equilibrium was observed for any of these three polymorphisms. The ApaI and TaqI genotypes showed a significant association indicating strong linkage disequilibrium. An excess of At and aT haplotypes was observed (shown in Table 4 ). The genotype frequencies did not differ from those previously observed for other Japanese populations 16, 37, 38 and the frequencies did not differ between the subjects included in the analysis and the subjects excluded from the analysis BMD. Some fundamental baseline characteristics were significantly different between the genotypes. In the premenopausal women, the age at menarche was lower in the subjects with AA genotype at the ApaI polymorphism than those with aa genotype (12.5 ± 0.1 versus 12.9 ± 0.1 years old, P = 0.034). In the postmenopausal women, the grip strength was higher in the subjects with Ff at the FokI polymorphism than those with FF (22.6 ± 0.3 versus 21.4 ± 0.3 kg, P = 0.012).
VDR genotypes and baseline BMD
The mean ± SEM values of baseline BMD at the lumbar spine, femoral neck, distal 1/3 site of the radius, and the ultradistal site of the forearm for ApaI, TaqI, and FokI genotypes in pre-and post-menopausal women are shown in Table 5 . The crude BMD at the distal 1/3 radius in the premenopausal subjects differed significantly among TaqI genotypes (the effect size of TaqI polymorphism calculated by ANOVA was 0.09). The mean BMD at this site was significantly higher for women with Tt genotype than for women with TT. This difference in BMD remained even after adjustment for age, height, and weight (the effect size of TaqI polymorphism calculated by ANCOVA was 0.10).
In the postmenopausal women, there was a significant association between FokI genotypes and BMD at the distal 1/3 radius (the effect size of FokI polymorphism calculated by ANOVA was 0.12). BMD at this site was higher in the subjects with Ff genotype than those with FF. However, after adjusting for age, height, and weight, this difference in BMD turned out to be insignificant (the effect size of FokI polymorphism calculated by ANCOVA was 0.09). No differences were found between the crude and adjusted BMD at other sites for FokI genotypes.
None of the individual polymorphisms defined by ApaI, TaqI and FokI restriction sites showed a consistent association with BMD over the skeletal sites measured in the present study.
After analysing three major genotypes (aaTT, AaTT, AaTt) assessed with ApaI and TaqI RFLP, we found that, in the premenopausal women, the crude BMD at the distal 1/3 radius in the subjects with AaTt genotype was significantly greater than that of the subjects with aaTT, while the BMD of the subjects with AaTT was intermediate (AaTt, 0.762 ± 0.006 n = 119; AaTT, 0.746 ± 0.006 n = 194; aaTT, 0.744 0.007 g/cm 2 n = 389, P = 0.028; the effect size of these genotypes calculated by ANOVA was 0.10). Adjustment for age, height, and weight did not attenuate the significance of this association (P = 0.009; the effect size of these genotypes calculated by ANCOVA in was 0.12).
Subsequently we analysed the effect of the carrier status for ApaI and TaqI haplotype (AT or aT) on BMD. There was no significant effect on BMD according to these haplotypes at any of the sites measured in this study.
We added grip strength and years since menopause into the ANCOVA model but this did not materially alter the results. In further analysis, we adjusted only for age, height, and weight.
VDR genotypes and follow-up BMD
Among 1434 women included in these analyses, 976 subjects (68.1%) completed the follow-up study. There was no significant difference in baseline characteristics between the baseline subjects and the follow-up subjects except for age (47.4 ± 0.5 versus 50.3 ± 0.5 years old, P Ͻ 0.001) and height (152.9 ± 0.2 versus 152.2 ± 0.2 cm, P = 0.015). There was no significant difference in baseline BMD at any of the skeletal sites between the baseline subjects and the follow-up subjects.
We separated the follow-up subjects into two groups based on the menopausal status at baseline and follow-up. One group consisted of the subjects who had been premenopausal at follow-up, denoted as F-premenopausal women. The other group consisted of the subjects who already had been postmenopausal at baseline, denoted as B-postmenopausal women. The absolute values of the annual per cent changes in VDR GENOTYPE IN REPRESENTATIVE SAMPLES 983 Expected frequencies under the assumption of no linkage disequilibrium were calculated using the frequencies of each allele (A, a, T, and t) and genotype (AA, Aa, aa, TT, Tt, and tt). BMD during the 3 years of follow-up were smaller in the F-premenopausal women than in the B-postmenopausal women (Table 2 ). In the subjects of the follow-up study, some fundamental baseline characteristics were significantly different between the genotypes in the B-postmenopausal women. The age at menarche was higher in the subjects with tt genotype than those with TT (17.2 ± 0.9 versus 15.5 ± 0.1 years old, P = 0.015). The baseline age was lower (63.8 ± 0.6 versus 66.2 ± 0.6 years old, P = 0.010), years since menopause was shorter (14.4 ± 0.7 versus 16.7 ± 0.6 years, P = 0.045) and grip strength was higher (23.0 ± 0.3 versus 21.5 ± 0.3 kg, P = 0.008) in the subjects with Ff genotype than those with FF. Table 6 presents the annual per cent changes in BMD during the 3 years of follow-up in subjects with different TaqI genotypes. There were significant differences in BMD change at the lumbar spine among TaqI genotypes in both the Fpremenopausal women and the B-postmenopausal women, as evaluated by ANOVA (each of the effect sizes of TaqI polymorphism calculated by ANOVA was 0.13). In the Fpremenopausal women, bone loss at the lumbar spine in the subjects with tt genotype was significantly greater than that of subjects with Tt or TT. In contrast, the subjects with tt genotype in the B-postmenopausal women showed a tendency toward bone gain at the lumbar spine, compared with the subjects with Tt, who showed a tendency toward bone loss. There was a significant difference between the BMD change at the lumbar spine of the B-postmenopausal women with tt and with Tt. However, the number of subjects with tt genotype was very small (the number of eligible subjects for analysis of BMD at the lumbar spine was four for the F-premenopausal women and six for the B-postmenopausal women). Comparing BMD at the lumbar spine between subjects with TT and with Tt, there was no significant difference in BMD change in either the Fpremenopausal women or the B-postmenopausal women.
No other difference in the BMD change was found between the genotypes of other polymorphisms.
Discussion
Osteoporosis is characterized by low bone mass and microarchitectural deterioration of bone tissue, resulting in an increased risk of fracture induced by fragility. 1, 39, 40 Twin and family studies have shown that osteoporosis has a strong genetic component and up to 50% of the variance in BMD has been attributed to genetic factors. [7] [8] [9] However, the identity of osteoporosis susceptibility genes has so far remained uncertain.
Morrison et al. first showed that the polymorphism in the 3' end region of the VDR gene, as determined by the restriction enzymes BsmI, ApaI, and TaqI, was related to BMD. 10 A great deal of attention was focused on this relationship, and these VDR polymorphisms were the most extensively studied genetic markers. However, the results from numerous subsequent studies on the association of these 3' end region polymorphisms with BMD have been highly inconsistent. Most of these studies were performed on Caucasian subjects. Even focusing solely on the existing studies of Asian people, we have found that the results of the association analyses are inconsistent. 26, 37, 38, [41] [42] [43] [44] [45] Moreover, two meta-analysis studies have failed to yield consistent results 46, 47 and two recent large population-based studies on Caucasians have also shown controversial results. 48, 49 Various potential causes for this discrepancy in the results have been advocated, such as arbitrariness due to small sample size, biased samples due to convenience sampling, confounding due to heterogeneity in genetic background, age, menstrual status, body size, or lifestyle factors in the study population. In addition, population admixture and linkage disequilibrium may explain the discrepancy. These polymorphisms do not change the amino acid sequence and are probably only markers in linkage disequilibrium with another functional polymorphism. Different linkage disequilibriums may exist in different populations: for example, Ingress et al. reported that the strength of the linkage disequilibrium between BsmI polymorphisms at intron 8 and the length of the poly (A) string at the 3' end untranslated region in the VDR gene varied with ethnicity. 25 Hence, this may cause different associations in different populations.
Arai et al. reported 16 that the variant of the FokI polymorphic site at the start codon which lacks the first three amino acids interacted more efficiently with transcription factor IIB and possessed elevated transcriptional activity. They reported that this polymorphism was related to BMD. Recent studies 50, 51 indicate that the effect of the FokI polymorphisms on BMD could prove to be less than the effect proposed by the study of Arai et al. Further, a functional analysis suggested that FokI polymorphisms did not relate to the differences in functions such as DNA binding and transactivation activity. 52 Although many polymorphisms in other candidate genes have been investigated, none of the contributions of these polymorphisms to the pathogenesis of osteoporosis has been found to be much larger than that originally reported by Morrison et al. It is difficult to conclude whether any individual polymorphism actually makes a significant contribution to the development of osteoporosis.
The extreme discordance of the results in a long series of studies on VDR polymorphisms, beginning with Morrison's reports, have provided us with an appropriate means of carrying on an association study for evaluating the effects of gene polymorphisms. To solve the problems in the design and analysis of the previous studies, it is necessary that: (1) the sample should be large enough to have sufficient statistical power; (2) the sample be representative of the study population; (3) the study design allow the control of confounding factors such as race, age, body size, and lifestyle; and (4) various instruments of measurement in the study have high reliability.
We performed this study in order to confirm the association of the VDR 3' region polymorphisms (ApaI and TaqI) and the start codon polymorphism (FokI) with BMD in Japanese women. Our present study has several advantages in design over the previous studies, as follows: (1) our sample consisted of more than 1400 subjects, sufficient for consolidating statistical power; (2) our sample was randomly selected from the general population in different region of Japan; and (3) our measurement of BMD and analysis of DNA was performed by highly reliable methods.
Still, the present study has some limitations. First, the study areas were not randomly selected from all the municipalities of Japan and did not include large cities. This might bias the study results. However, the frequencies of the genotypes were not significantly different from the results of previous studies on Japanese women. 16, 37, 38 The height and weight of the subjects were similar to the Japanese average for the same ages. 53 Therefore, it is likely that the characteristics of the present subjects were not substantially biased. Second, the follow-up rate was not very high and there were small differences in the basic characteristics between the baseline subjects and follow-up subjects. This was caused by the low follow-up rate of the subjects under the age of 30, which might have biased the results for the F-premenopausal women. Practically, relatively small changes in BMD can be observed in the younger generation: therefore, the predicted result in the case of a high follow-up rate would not significantly differ from the observed result. The low follow-up rate resulted in few subjects with tt genotype. The effect size of the t-test on tt and Tt genotypes in the F-premenopausal women is Ͻ1. 45 and it could not be detected at statistical power = 0.8 and alpha = 0.05. However, the actual effect size of each polymorphism of the three VDR genotypes calculated by ANOVA in this study was smaller than 0.14 in both premenopausal and postmenopausal women. Therefore, even if we got more subjects and statistically significant results at stronger power, the VDR polymorphisms would not be shown to have substantial effect on BMD in Japanese women.
Third, many genes have been reported to affect bone mass, and some of them have been thought to interact with the VDR genotype and thus to influence BMD. 54, 55 Furthermore, environmental factors such as calcium intake, physical activity, and smoking habits may confound the VDR genotypes. Particularly, the interaction of the VDR genotype with calcium intake or confounding effects connected to dietary calcium intake may explain the discrepancies in the results of the associations between the VDR genotypes and BMD in many studies. [56] [57] [58] In the present study, since the level of BMD adjusted for calcium intake was not different from crude BMD (data not shown), we did not perform further analysis to find out whether the differences in calcium intake caused a difference in the level of BMD over the VDR genotypes. The average calcium intake in our study subjects was similar to the Japanese average 53 and to the results of previous studies on Japanese women at the respective ages. 59 Therefore, it is considered that the results of our present study could reflect the effect of the VDR genotypes on BMD under the usual nutritional calcium intake conditions for Japanese women. In addition, other lifestyle factors such as physical activity and smoking habits did not differ greatly between the genotypes in our study (data not shown). Heterogeneity in these factors over the different allele groups was assumed to be small. We did not present further analyses of the interaction with or confounding with these lifestyle factors in this report, because these analyses would not materially alter our conclusion.
In this large-scale cohort study on representative samples of the Japanese female population, we evaluated the association between BMD and three VDR genotypes as follows: start codon polymorphism (FokI) does not have an independent effect on BMD, either in pre-or post-menopausal women; in 3' end polymorphisms (ApaI and TaqI), we detected some differences in BMD at the 1/3 radius among the TaqI genotypes and 3 major genotypes (aaTT, AaTT, AaTt) determined with both ApaI and TaqI. We also detected a difference in annual BMD changes in the lumbar spine among the TaqI genotypes. However, the effects of particular alleles or genotypes on BMD were mutually inconsistent. ApaI and TaqI polymorphisms in the VDR gene were not found to have consistent enough associations with BMD to enable the prediction of osteoporosis in either pre-or post-menopausal women. In conclusion, the effect of the previously reported VDR polymorphisms on bone mass is negligible in Japanese women. In future studies, the effects of other candidate genes on BMD and gene-gene or gene-environment interactions should be researched.
